Search results
FTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in By Investing.com
Investing.com· 3 days agoOn Tuesday, the Federal Trade Commission (FTC) said it is challenging hundreds of what it calls...
Rebalancing IP Protection and Employee Mobility? | Daily Business Review
Law.com· 2 days agoOne of the more challenging aspects of practicing intellectual property (IP) law is helping...
With its $240 million fertilizer gamble in peril, Iowa should give up on giveaways
The Des Moines Register via Yahoo Finance· 1 day agoOpinion: Will Iowa learn after our quarter-billion-dollar effort to preserve fertilizer competition...
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
PYMNTS.com· 1 day agoThe Federal Trade Commission (FTC) has accused former Pioneer Natural Resources CEO, Scott Sheffield, of allegedly colluding with OPEC officials to manipulate oil output and inflate prices.
Biden administration faces onslaught of lawsuits as business groups claim regulatory overreach
CNBC· 4 days agoWhen the Federal Trade Commission finalized a rule earlier this month banning noncompete clauses,...
Regulators extend comment period on private equity healthcare inquiry
Pensions & Investments· 1 day agoFederal regulators are giving the public more time to respond to a request for information examining acquisitions by private equity companies in the healthcare sector. The RFI seeks to understand ...
Biden administration faces onslaught of lawsuits as business groups claim regulatory overreach
NBC Miami· 4 days agoThe Biden administration faces a wave of lawsuits targeting its regulatory agenda, as business and...
Pioneer Natural Resources co-founder will be barred from board in deal for Exxon merger
Dallas Morning News· 2 days agoThe Federal Trade Commission is poised to greenlight Exxon Mobil’s $60 billion purchase of...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 3 days agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 3 days ago“By filing bogus patent listings, pharma companies block competition and inflate the cost of...